Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas A. Dix | M | - |
Argolyn Bioscience, Inc.
 Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | - |
| Mark D. Campbell | M | - |
University of South Carolina
| 5 years |
| James McNab | M | 80 |
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | 3 years |
| J. Bratton Fennel | M | - |
University of South Carolina
| 5 years |
| Jeremy S. Elliott | M | - |
University of South Carolina
| 5 years |
| Pearce Gilbert | M | - |
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | 7 years |
| Woody Alpern | M | - |
University of South Carolina
| 5 years |
| Micah Sanders Porter | M | - |
University of South Carolina
| 6 years |
| W. Amick | M | 81 |
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | - |
| J. R. Green | M | - |
University of South Carolina
| 27 years |
| Andrew Lawrence | M | 53 |
University of South Carolina
| 4 years |
| Susan Marie Sproule | F | - |
University of South Carolina
| 4 years |
| Changgyou Kim | M | - |
University of South Carolina
| 3 years |
| Charles John Dean | M | - |
University of South Carolina
| 4 years |
| Christopher Papagni | M | - |
University of South Carolina
| 2 years |
| Lisa Leask | F | - |
University of South Carolina
| 4 years |
| Timothy M. Mitchell | M | - |
University of South Carolina
| 4 years |
| Gene Carlson | M | - |
University of South Carolina
| 4 years |
| Lynne Soughley | F | - |
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | - |
| Ann Snelling Gluse | F | - |
University of South Carolina
| 4 years |
| Frank Sanders | M | - |
University of South Carolina
| 3 years |
| George W. Koszalka | M | - |
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | - |
| Willis Lee | M | 64 |
University of South Carolina
| 1 years |
| Earl Azimov | M | 62 |
University of South Carolina
| 4 years |
| Jae-Yong Lee | M | 71 |
University of South Carolina
| 2 years |
| Michael DeCarlo | M | - |
University of South Carolina
| 4 years |
| Byung-Seo Kang | M | 74 |
University of South Carolina
| 3 years |
| Caroline Efird | F | - |
University of South Carolina
| 4 years |
| Somnuek Anakwat | M | 66 |
University of South Carolina
| 4 years |
| Ronald Felt | M | 66 |
University of South Carolina
| 1 years |
| Taylor Tenison Stokes | M | 57 |
University of South Carolina
| 4 years |
| Roger Glenn Ward | M | - |
University of South Carolina
| 5 years |
| Allen J. Morrison | M | 65 |
University of South Carolina
| 3 years |
| Martin Bott | M | - |
University of South Carolina
| 1 years |
| Mark Johnston | M | - |
University of South Carolina
| 4 years |
| Inez Tenenbaum | M | - |
University of South Carolina
| 3 years |
| I. Ume | M | - |
University of South Carolina
| 3 years |
| Fernando Teixeira dos Santos | M | 72 |
University of South Carolina
| 3 years |
| Chris Murphy | M | - |
University of South Carolina
| 4 years |
| Gerald Perritt | M | - |
University of South Carolina
| 4 years |
| Robert C. Andrews | M | - |
University of South Carolina
| 3 years |
| Joe Brownlee | M | - |
University of South Carolina
| 3 years |
| Scott Elser | M | - |
University of South Carolina
| 5 years |
| Mark R. Davies | M | - |
University of South Carolina
| 4 years |
| Dieter Schill | M | - |
University of South Carolina
| 1 years |
| Donald T. Locke | M | 64 |
University of South Carolina
| 2 years |
| Charles A. Attal | M | 64 |
University of South Carolina
| 3 years |
| M. Wingo | M | 52 |
University of South Carolina
| 4 years |
| Dennis Dougherty | M | 76 |
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | - |
| Kimberly L. Koerner | F | - |
University of South Carolina
| 4 years |
| Neil E. Grayson | M | - |
University of South Carolina
| 3 years |
| Richard C. Coggins | M | 66 |
University of South Carolina
| 4 years |
| Scott R. Waltmann | M | - |
University of South Carolina
| 4 years |
| David E. Dukes | M | 65 |
University of South Carolina
| 3 years |
| Paul de Vine | M | - |
University of South Carolina
| 4 years |
| Thomas Caskey | M | 86 |
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | - |
| M. Nixon Ellis | M | - |
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | - |
| Joanne M. Rogers | F | 75 |
University of South Carolina
| 1 years |
| David Ashley Miller | M | 55 |
University of South Carolina
| 4 years |
| John Hobbs | M | 61 |
University of South Carolina
| 4 years |
| Robert H. Mathewes | M | 56 |
University of South Carolina
| 4 years |
| Barry I. Kalinsky | M | 63 |
University of South Carolina
| 3 years |
| Brent Steven Robinson | M | - |
University of South Carolina
| 4 years |
| Patrick Weston | M | - |
University of South Carolina
| 4 years |
| Robert Motley | M | - |
University of South Carolina
| 4 years |
| Daniel Dixon | M | - |
University of South Carolina
| 4 years |
| Jonathan Hastings | M | 62 |
University of South Carolina
| 1 years |
| Michael Crapps | M | 65 |
University of South Carolina
| 2 years |
| F. Harvin Ray | M | 59 |
University of South Carolina
| 4 years |
| Geeta S. Vemuri | M | - |
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | - |
| Michael P. Bishof | M | - |
University of South Carolina
| 4 years |
| Greg Brewer | M | - |
University of South Carolina
| 4 years |
| Mark S. Simpson | M | 62 |
University of South Carolina
| 3 years |
| F. Justin Strickland | M | 60 |
University of South Carolina
| 4 years |
| Lawrence J. Scott | M | - |
University of South Carolina
| 3 years |
| Ed Reitler | M | - |
University of South Carolina
| 2 years |
| Justin Brower | M | - |
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | 5 years |
| Kent D. Talbert | M | - |
University of South Carolina
| 3 years |
| Brian Jeffrey Meath | M | 62 |
University of South Carolina
| 2 years |
| Vince Burgess | M | 59 |
University of South Carolina
| 4 years |
| Duane A. Owens | M | 55 |
University of South Carolina
| 4 years |
| Paige Parks | F | - |
University of South Carolina
| 4 years |
| McDonald Sean | M | - |
University of South Carolina
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 83 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Monty Hughes
- Personal Network
